Research Topic

Neuroprotection in Synaptic Signalling During Neurological Disorders

About this Research Topic

Some of the most devastating and costly conditions in the world arise from different types of neurological and neurodegenerative disorders. Nearly one-third of the world population suffers from neurological diseases, including Parkinson's and Alzheimer's diseases, multiple sclerosis, epilepsy, as well as other neurological disorders such as spinal cord injury. In some diseases, the onset of symptoms appear early in childhood, but many other symptoms are substantially delayed; arising in adolescence or young adulthood. Animal models of brain injury are crucial in elucidating the underlying mechanisms and developing strategies for new treatments.

Over-release of glutamate can be observed a few seconds after a hypoxic injury episode before rapidly returning to control values. Moreover, neuronal death can occur several days following the hypoxic episode in question. Different types of signals may be involved in late neuronal cell death and they could be triggered at the synaptic level. Changes in postsynaptic densities have been described several months after brain injury and correlate with alterations in animal behavior. Among the new therapeutic strategies tested mainly experimentally, only hypothermia has shown clinical benefits to some extent. Up to now, there are no well-established treatments for brain repair. Hence, neuroprotection becomes imperative. The understanding of the pathophysiology of brain injury contributes to the identification of neuroprotective agents. In this sense, synapses might be one of the main targets to find neuroprotective candidates.

The audience is meant to be mainly experts in the field. This Research Topic focuses on neuroprotective strategies for the brain, their possible pathways, and the use of pharmacological analogs. Potential topics, mainly related to the synaptic role in brain injury, include:

• Biochemical and physiological aspects of neuroprotective agents focusing on synaptic modifications
• Pathophysiological aspects of brain hypoxia
• Pharmacological- and genetic-targeting strategies
• Beneficial effects of neuroprotective agents on neuroplasticity and behavior
• Clinical-related aspects of neuroprotective agents on associated damage and recovery following perinatal asphyxia
• An integrative in-silico approach for neuroprotective agents


Keywords: synapse-intracellular pathway, translational medicine, neurodegeneration, pharmacological strategies


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Some of the most devastating and costly conditions in the world arise from different types of neurological and neurodegenerative disorders. Nearly one-third of the world population suffers from neurological diseases, including Parkinson's and Alzheimer's diseases, multiple sclerosis, epilepsy, as well as other neurological disorders such as spinal cord injury. In some diseases, the onset of symptoms appear early in childhood, but many other symptoms are substantially delayed; arising in adolescence or young adulthood. Animal models of brain injury are crucial in elucidating the underlying mechanisms and developing strategies for new treatments.

Over-release of glutamate can be observed a few seconds after a hypoxic injury episode before rapidly returning to control values. Moreover, neuronal death can occur several days following the hypoxic episode in question. Different types of signals may be involved in late neuronal cell death and they could be triggered at the synaptic level. Changes in postsynaptic densities have been described several months after brain injury and correlate with alterations in animal behavior. Among the new therapeutic strategies tested mainly experimentally, only hypothermia has shown clinical benefits to some extent. Up to now, there are no well-established treatments for brain repair. Hence, neuroprotection becomes imperative. The understanding of the pathophysiology of brain injury contributes to the identification of neuroprotective agents. In this sense, synapses might be one of the main targets to find neuroprotective candidates.

The audience is meant to be mainly experts in the field. This Research Topic focuses on neuroprotective strategies for the brain, their possible pathways, and the use of pharmacological analogs. Potential topics, mainly related to the synaptic role in brain injury, include:

• Biochemical and physiological aspects of neuroprotective agents focusing on synaptic modifications
• Pathophysiological aspects of brain hypoxia
• Pharmacological- and genetic-targeting strategies
• Beneficial effects of neuroprotective agents on neuroplasticity and behavior
• Clinical-related aspects of neuroprotective agents on associated damage and recovery following perinatal asphyxia
• An integrative in-silico approach for neuroprotective agents


Keywords: synapse-intracellular pathway, translational medicine, neurodegeneration, pharmacological strategies


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

08 April 2019 Abstract
06 August 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

08 April 2019 Abstract
06 August 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top
);